No ano passado, Medtronic PLC gerou US$ 7.50B em seu segmento de melhor desempenho, Cardiac Rhythm & Heart Failure. A região Rest of World teve a maior contribuição, com US$ 18.12B no período. No último trimestre, Medtronic PLC registrou receita de US$ 2.11B no período encerrado em 2026-04-24, proveniente principalmente do segmento Cardiac Rhythm & Heart Failure. A região Rest of World teve a maior contribuição, com receita de US$ 4.90B.

Por Empresa

Receita

Proporção

Anual

Anual

Trimestral

Cardiac Rhythm & Heart Failure

Surgical & Endoscopy

Cranial & Spinal Technologies

Coronary & Peripheral Vascular

Specialty Therapies

Structural Heart & Aortic

Neuromodulation

Patient Monitoring & Respiratory Interventions

Other

Other adjustments

Coronary & Peripheral Vascular

Brain Therapies

Spine

Pain Therapies

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Cardiac Rhythm & Heart Failure

7.50B(22.57%)

6.39B(20.77%)

6.00B(20.07%)

5.78B(19.31%)

5.85B(19.94%)

5.58B(20.16%)

5.14B(19.37%)

5.85B(20.77%)

Surgical & Endoscopy

6.76B(20.34%)

6.50B(21.11%)

6.51B(21.78%)

6.15B(20.54%)

6.54B(22.30%)

5.44B(19.63%)

5.51B(20.77%)

5.75B(20.43%)

Cranial & Spinal Technologies

5.22B(15.70%)

4.97B(16.16%)

4.76B(15.92%)

4.45B(14.86%)

4.46B(15.18%)

4.29B(15.48%)

--(--)

Coronary & Peripheral Vascular

3.82B(11.48%)

--(--)

Specialty Therapies

3.00B(9.01%)

2.94B(9.55%)

2.90B(9.72%)

2.81B(9.40%)

2.59B(8.83%)

2.31B(8.33%)

1.19B(4.49%)

1.64B(5.83%)

Structural Heart & Aortic

2.66B(7.99%)

3.55B(11.55%)

3.36B(11.24%)

3.36B(11.23%)

3.06B(10.41%)

2.35B(8.50%)

1.79B(6.73%)

1.93B(6.84%)

Neuromodulation

2.07B(6.22%)

1.93B(6.28%)

1.75B(5.84%)

1.69B(5.65%)

1.74B(5.91%)

1.60B(5.78%)

--(--)

Patient Monitoring & Respiratory Interventions

2.05B(6.17%)

1.91B(6.20%)

1.91B(6.39%)

1.84B(6.13%)

1.93B(6.56%)

3.30B(11.90%)

2.84B(10.70%)

2.73B(9.67%)

Other

135.00M(0.41%)

137.00M(0.45%)

221.00M(0.74%)

495.00M(1.65%)

727.00M(2.48%)

--(--)

Other adjustments

39.00M(0.12%)

-90.00M(-0.29%)

--(--)

Coronary & Peripheral Vascular

--(--)

2.54B(8.24%)

2.48B(8.29%)

3.36B(11.23%)

2.46B(8.38%)

2.83B(10.23%)

3.54B(13.34%)

3.73B(13.24%)

Brain Therapies

--(--)

2.92B(11.01%)

2.60B(9.25%)

Spine

--(--)

2.50B(9.43%)

2.65B(9.42%)

Pain Therapies

--(--)

1.11B(4.17%)

1.28B(4.56%)

Por Região

Receita

Proporção

Anual

Anual

Trimestral

Rest of World

United States

Ireland

Americas

EMEA

Asia Pacific

Other Foreign

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

Rest of World

18.12B(49.82%)

16.25B(48.45%)

15.69B(48.48%)

14.76B(47.25%)

15.45B(48.76%)

14.49B(48.12%)

13.91B(48.11%)

14.27B(46.71%)

13.99B(46.72%)

12.98B(43.68%)

12.33B(42.77%)

--(--)

United States

18.10B(49.78%)

17.17B(51.20%)

16.56B(51.17%)

16.37B(52.43%)

16.14B(50.92%)

15.53B(51.55%)

14.92B(51.60%)

16.19B(53.00%)

15.88B(53.00%)

16.66B(56.09%)

16.42B(56.96%)

--(--)

Ireland

143.00M(0.39%)

116.00M(0.35%)

113.00M(0.35%)

98.00M(0.31%)

101.00M(0.32%)

100.00M(0.33%)

85.00M(0.29%)

91.00M(0.30%)

85.00M(0.28%)

69.00M(0.23%)

79.00M(0.27%)

--(--)

Americas

--(--)

12.13B(59.84%)

9.92B(58.35%)

9.76B(58.84%)

8.83B(54.55%)

EMEA

--(--)

5.06B(24.99%)

4.48B(26.36%)

4.22B(25.47%)

4.31B(26.65%)

Asia Pacific

--(--)

2.06B(10.16%)

1.78B(10.44%)

1.89B(11.37%)

2.40B(14.82%)

Other Foreign

--(--)

1.01B(5.00%)

824.00M(4.85%)

718.00M(4.33%)

644.00M(3.98%)